silicon phthalocyanine pc4 has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Değirmencioğlu, İ; Eyüpoğlu, FC; Sarı, C | 1 |
| Celep Eyüpoğlu, F; Değirmencioğlu, İ; Nalçaoğlu, A; Sarı, C | 1 |
| Livingston, M; Master, AM; Oleinick, NL; Sen Gupta, A | 1 |
3 other study(ies) available for silicon phthalocyanine pc4 and Breast Neoplasms
| Article | Year |
|---|---|
Synthesis and characterization of novel Schiff base-silicon (IV) phthalocyanine complex for photodynamic therapy of breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Schiff Bases; Spectroscopy, Fourier Transform Infrared | 2023 |
Tumor-selective new piperazine-fragmented silicon phthalocyanines initiate cell death in breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Gene Expression Regulation; Humans; Indoles; Optical Imaging; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Piperazine; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species | 2021 |
Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Indoles; Mice; Mice, Nude; Nanomedicine; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Tomography, Emission-Computed, Single-Photon | 2012 |